Rho Experts Discuss the Importance of Early Patient Involvement in Clinical Trial Design in Free Webinar

DURHAM, NC - Jun 6, 2019 - Rho Experts Discuss the Importance of Early Patient Involvement in

Clinical Trial Design in Free Webinar

WHAT:                 Patient-centricity gets a lot of buzz as an essential aspect in research, drug development and disease management. Improving the lives of patients requires a deep understanding of their medical conditions, experiences, needs and priorities. As the term suggests, patient centricity is about putting the patient, and their needs and concerns at the heart of what we do.  It’s about learning to view patients as partners in the research process, listening to their needs and rethinking the way we conduct research.

The free webinar, “The Importance of Early Patient Involvement in Clinical Trial Design,” will take place on Wednesday, June 12 from 1-2 p.m. EST, and will look at the benefits of involving patients in the planning of a clinical trial. The featured speakers will discuss:

ü  Where in the process to get patient input-from protocol reviews to endpoint selection to assessments

ü  How patient input can benefit enrollment, compliance, and outcomes

ü  What tactics can be used to elicit meaningful input

WHO:                    Jamie Arnott, BSN, RN, OCN®, Senior Project Director, Rho

                                Ryan Bailey, MA, Senior Clinical Researcher, Rho

                                Samantha Hoopes, PhD, RAC, Research Scientist, Rho

                                Dana Dunne, BS, CTRA, Clinical Team Lead, Rho

WHEN:                 Wednesday, June 12, 1-2 p.m. EST

WHERE:               Register to attend this free webinar at this link.

DETAILS:              For media inquiries, please contact Jordan Lockhart at Largemouth Communications,                                       919-459-6461, jordan@largemouthpr.com.   

ABOUT:                Rho, a privately-held, contract research organization (CRO) located in Research Triangle Park, NC, provides a full range of clinical research services across the entire drug development process. For 35 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Facebook, LinkedIn and Twitter.